Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Human Metabolomics Institute Inc. has 1 pending office action in Chemistry & Materials. The matter is assigned to 1 distinct examiner and 1 distinct art unit, creating a single, clearly defined prosecution path.
ALABI, OYELEYE A is the busiest examiner, with 1 pending matter. Counsel can concentrate on the outstanding action and the expectations of the assigned chemistry and materials art unit. Because the data shows no distribution across multiple examiners or art units, the profile does not call for portfolio-wide coordination or differentiated examiner strategies.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALABI, OYELEYE A | 1 | 83.9% | +23.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267469 | APPLICATION OF NEONATAL BILIARY ATRESIA BIOMARKER AND DETECTION METHOD FOR SAME | ALABI, OYELEYE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267469 | APPLICATION OF NEONATAL BILIARY ATRESIA BIOMARKER AND DETECTION METHOD FOR SAME | ALABI, OYELEYE A | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18267469 | APPLICATION OF NEONATAL BILIARY ATRESIA BIOMARKER AND DETECTION METHOD FOR SAME | ALABI, OYELEYE A | 1797 | §103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHuman Metabolomics Institute Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Oyeleye A Alabi has the most, with 1 of Human Metabolomics Institute Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
